These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3246714)

  • 21. [Treatment of acute leukemia with newly synthesized N4-behenoyl-l-beta-D-arabinofuranosylcytosine (BH-AC) (author's transl)].
    Sueyama H; Oguro M; Takagi T
    Rinsho Ketsueki; 1981 Jul; 22(7):1109-15. PubMed ID: 7328768
    [No Abstract]   [Full Text] [Related]  

  • 22. Secondary chronic myelomonocytic leukemia with monosomy 7 after successful treatment of acute promyelocytic leukemia.
    Jeddi R; Gouider E; Benneji H; Mnif S; Ben Abid H; Belhadjali Z; Meddeb B
    Pathol Biol (Paris); 2008 May; 56(3):162-3. PubMed ID: 18178033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cutaneous infiltratiton by chronic myelononocytic leukemia: presentation of three cases].
    Prada Garcia C; Sanchez Sambucety P; Rodriguez Prieto MÁ
    Dermatol Online J; 2013 Nov; 19(11):20408. PubMed ID: 24314783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on human erythrocytes].
    Moriguchi T; Kakita T; Nishimura T; Kubo A; Ueda T; Nakamura T; Sasada M; Uchino H
    Rinsho Ketsueki; 1987 Sep; 28(9):1568-75. PubMed ID: 3437519
    [No Abstract]   [Full Text] [Related]  

  • 25. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
    Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM
    Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-renewal capacity of leukemic blast progenitor cells.
    Buick RN; Chang LJ; Messner HA; Curtis JE; McCulloch EA
    Cancer Res; 1981 Nov; 41(11 Pt 2):4849-52. PubMed ID: 6945908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
    Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
    Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cytogenetic findings in a four-way t(1;12;5;12)(p36;p13;q33;q24) underlying the ETV6-PDGFRB fusion gene in chronic myelomonocytic leukemia.
    Crescenzi B; La Starza R; Nozzoli C; Ciolli S; Matteucci C; Romoli S; Rigacci L; Gorello P; Bosi A; Martelli MF; Marynen P; Mecucci C
    Cancer Genet Cytogenet; 2007 Jul; 176(1):67-71. PubMed ID: 17574967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. inv(2)(p23q13)/RAN-binding protein 2 (RANBP2)-ALK fusion gene in myeloid leukemia that developed in an elderly woman.
    Maesako Y; Izumi K; Okamori S; Takeoka K; Kishimori C; Okumura A; Honjo G; Akasaka T; Ohno H
    Int J Hematol; 2014 Feb; 99(2):202-7. PubMed ID: 24307515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inv(16) and eosinophilia in CMMoL.
    Bennett JM
    Cancer Genet Cytogenet; 1998 Feb; 101(1):81. PubMed ID: 9460508
    [No Abstract]   [Full Text] [Related]  

  • 31. Monosomy 15 in chronic myelomonocytic leukemia. description of a case and review of the literature.
    Zamora L; Espinet B; Salido M; Florensa L; Woessner S; Pedro C; Serrtano S; Solé F
    Cancer Genet Cytogenet; 2002 Apr; 134(2):165-7. PubMed ID: 12034533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic effect of ranimustine(MCNU) on myeloproliferative disorder and chronic myelomonocytic leukemia].
    Maeda S; Okabe M; Kurosawa M; Kunieda Y; Imamura M; Morioka M; Sakurada K; Miyazaki T; Sukegawa M
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):251-8. PubMed ID: 1992919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic myelomonocytic leukemia with der(9)t(1;9)(q11;q34) as a sole abnormality.
    Suh B; Park TS; Kim JS; Song J; Kim J; Yoo JH; Choi JR
    Ann Clin Lab Sci; 2009; 39(3):307-12. PubMed ID: 19667417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of acute leukemia with 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine hydrochloride (cyclocytidine) (author's transl)].
    Masaoka T; Hasegawa Y; Tatsumi N; Nakamura H; Yoshitake J
    Rinsho Ketsueki; 1973 Aug; 14(8):877-81. PubMed ID: 4797128
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and pharmacokinetic studies of high dose N4-behenoyl-1-beta-D-arabinofuranosylcytosine].
    Yoshida T; Nakamura S; Ohtake S; Ito K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1820-4. PubMed ID: 3592717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.
    Boula AM; Mantadakis E; Xilouri IM; Christoforidou AV; Foudoulakis AM; Samonis G
    Am J Hematol; 2005 Jul; 79(3):216-9. PubMed ID: 15981233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex rearrangement of chromosomes 1, 7, and 16 in chronic myelomonocytic leukemia.
    Fan YS; Rizkalla K; Barr RM
    Cancer Genet Cytogenet; 1999 Jul; 112(2):190-2. PubMed ID: 10686954
    [No Abstract]   [Full Text] [Related]  

  • 38. Paroxysmal nocturnal hemoglobinuria: termination in acute monocytic leukemia and reappearance after chemotherapy with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) and vincristine.
    Kawano F; Chosa M; Matsuoka M; Oyamada N; Takatsuki K
    Jpn J Clin Oncol; 1987 Jun; 17(2):123-8. PubMed ID: 3475490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase I clinical and pharmacokinetic study of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine.
    Ohno R; Kimura K; Ota K; Miura Y; Hoshino A; Hattori K; Hirano M; Ito M; Maekawa T; Nakamura T
    Med Oncol Tumor Pharmacother; 1987; 4(2):67-73. PubMed ID: 3669779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Langerhans cell histiocytosis and myelomonocytic leukemia: a non-fortuitous association].
    Baikian B; Descamps V; Grossin M; Marinho E; Picard C; Aitken G; Sigal M; Crickx B; Belaich S
    Ann Dermatol Venereol; 1999 May; 126(5):409-11. PubMed ID: 10434103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.